《Human Vaccines & Immunotherapeutics》雜志的最新年發文量為452篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在生物工程與應用微生物領域的學術影響力。
該刊聚焦于醫學-生物工程與應用微生物領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 一般,3-6周 。
Human Vaccines & Immunotherapeutics 雜志發文統計
文章名稱引用次數
- Talimogene laherparepvec: First in class oncolytic virotherapy56
- Adjuvanted influenza vaccines40
- Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literature36
- Measuring trust in vaccination: A systematic review31
- A review of Dengvaxia?: development to deployment29
- Investigating Italian parents' vaccine hesitancy: A cross-sectional survey25
- Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness20
- Vaccination knowledge and acceptability among pregnant women in Italy19
- Health literacy and vaccination: A systematic review19
- HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe18
國家/地區發文量
- USA479
- CHINA MAINLAND267
- Italy117
- England97
- Belgium86
- Canada82
- France70
- Australia69
- India67
- Japan55
